company background image
JPH logo

Jerusalem Pharmaceuticals PLSE:JPH Stock Report

Last Price

US$3.80

Market Cap

US$68.4m

7D

0%

1Y

0%

Updated

01 Feb, 2025

Data

Company Financials

Jerusalem Pharmaceuticals Co. Ltd.

PLSE:JPH Stock Report

Market Cap: US$68.4m

JPH Stock Overview

Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. More details

JPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Jerusalem Pharmaceuticals Co. Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Jerusalem Pharmaceuticals
Historical stock prices
Current Share PriceUS$3.80
52 Week HighUS$3.84
52 Week LowUS$3.49
Beta0.13
1 Month Change-0.78%
3 Month Change6.15%
1 Year Change0%
3 Year Change39.19%
5 Year Change46.72%
Change since IPO208.71%

Recent News & Updates

Recent updates

Shareholder Returns

JPHPS PharmaceuticalsPS Market
7D0%0.3%-0.02%
1Y0%11.2%-9.6%

Return vs Industry: JPH underperformed the PS Pharmaceuticals industry which returned 11.2% over the past year.

Return vs Market: JPH exceeded the PS Market which returned -9.6% over the past year.

Price Volatility

Is JPH's price volatile compared to industry and market?
JPH volatility
JPH Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement5.2%
10% most volatile stocks in PS Market6.1%
10% least volatile stocks in PS Market2.0%

Stable Share Price: JPH's share price has been volatile over the past 3 months compared to the PS market.

Volatility Over Time: Insufficient data to determine JPH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1969523Mohammed Mahmoud Masroujiwww.jepharm.ps

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions.

Jerusalem Pharmaceuticals Co. Ltd. Fundamentals Summary

How do Jerusalem Pharmaceuticals's earnings and revenue compare to its market cap?
JPH fundamental statistics
Market capUS$68.40m
Earnings (TTM)US$4.11m
Revenue (TTM)US$37.45m

16.6x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JPH income statement (TTM)
RevenueUS$37.45m
Cost of RevenueUS$18.40m
Gross ProfitUS$19.05m
Other ExpensesUS$14.94m
EarningsUS$4.11m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.23
Gross Margin50.88%
Net Profit Margin10.98%
Debt/Equity Ratio1.9%

How did JPH perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

44%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 18:30
End of Day Share Price 2025/01/28 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jerusalem Pharmaceuticals Co. Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution